Preparing your results

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Do treatment improvements in PTSD severity affect substance use outcomes? A secondary analysis from a randomized clinical trial in NIDA's Clinical Trials Network.

OBJECTIVE: The purpose of the analysis was to examine the temporal course of improvement in symptoms of posttraumatic stress disorder (PTSD) and substance use disorder among women in outpatient substance abuse treatment. METHOD: Participants were 353 women randomly assigned to 12 sessions of either trauma-focused or health education group treatment. PTSD and substance use assessments were conducted during treatment and posttreatment at 1 week and after 3, 6, and 12 months. A continuous Markov model was fit on four defined response categories (nonresponse, substance use response, PTSD response, or global response [improvement in both PTSD and substance use]) to investigate the temporal association between improvement in PTSD and substance use symptom severity during the study's treatment phase. A generalized linear model was applied to test this relationship over the follow-up period. RESULTS: Subjects exhibiting nonresponse, substance use response, or global response tended to maintain original classification; subjects exhibiting PTSD response were significantly more likely to transition to global response over time, indicating maintained PTSD improvement was associated with subsequent substance use improvement. Trauma-focused treatment was significantly more effective than health education in achieving substance use improvement, but only among those who were heavy substance users at baseline and had achieved significant PTSD reductions. CONCLUSIONS: PTSD severity reductions were more likely to be associated with substance use improvement, with minimal evidence of substance use symptom reduction improving PTSD symptoms. Results support the self-medication model of coping with PTSD symptoms and an empirical basis for integrated interventions for improved substance use outcomes in patients with severe symptoms.

Pubmed ID: 19917596


  • Hien DA
  • Jiang H
  • Campbell AN
  • Hu MC
  • Miele GM
  • Cohen LR
  • Brigham GS
  • Capstick C
  • Kulaga A
  • Robinson J
  • Suarez-Morales L
  • Nunes EV


The American journal of psychiatry

Publication Data

January 13, 2010

Associated Grants

  • Agency: NIDA NIH HHS, Id: K24 DA022412
  • Agency: NIDA NIH HHS, Id: K24DA022412
  • Agency: NIDA NIH HHS, Id: U10 DA013035
  • Agency: NIDA NIH HHS, Id: U10 DA013035-01A1
  • Agency: NIDA NIH HHS, Id: U10 DA013035-02
  • Agency: NIDA NIH HHS, Id: U10 DA013035-02S1
  • Agency: NIDA NIH HHS, Id: U10DA013046
  • Agency: NIDA NIH HHS, Id: U10DA013720
  • Agency: NIDA NIH HHS, Id: U10DA13035
  • Agency: NIDA NIH HHS, Id: U10DA13038
  • Agency: NIDA NIH HHS, Id: U10DA13714
  • Agency: NIDA NIH HHS, Id: U10DA13727
  • Agency: NIDA NIH HHS, Id: U10DA13732

Mesh Terms

  • Adult
  • Alcoholism
  • Cognitive Therapy
  • Comorbidity
  • Diagnosis, Dual (Psychiatry)
  • Female
  • Follow-Up Studies
  • Humans
  • Life Change Events
  • Longitudinal Studies
  • Markov Chains
  • National Institute on Drug Abuse (U.S.)
  • Patient Education as Topic
  • Psychotherapy, Group
  • Severity of Illness Index
  • Stress Disorders, Post-Traumatic
  • Substance-Related Disorders
  • Treatment Outcome
  • United States